Evolution Research Group Revenue and Competitors

Evolution Research Group represents Thievon-Wright Consulting Group and an elite 17-member network of owned and affiliate clinical research sites focused on conducting simple and highly complex trials in psychiatric and neurologic disorders, non-CNS indications, and early phase drug development. Our network is comprised of 18 research facilities including 11 Clinical Pharmacology/Clinical Research/Pediatric and Adolescent Units, providing access to over 400 beds. Thievon-Wright Consulting Group (TWCG) offers consulting services to pharmaceutical and CRO clients, including access to key opinion leaders in Schizophrenia, Pain, Alzheimer's disease, Sleep Disorders, Depression, Hepatic/Renal Impairment, and Clinical Pharmacology. In addition, TWCG also offers general consulting in study design, protocol review and budget planning, vendor resources, study feasibility and site recommendations. The Evolution Research Group network of Portfolio and Affiliate Sites focuses in specialized populations and normal healthy volunteers. KOLs in Schizophrenia, Clinical Pharmacology, Post-Op Pain, Pain, Alzheimer's disease, Sleep Disorders, Depression, Podiatry General Consulting: Study Design, Protocol Review and Budget Planning Scientific Advisory Board Planning and Implementation Vendor Resources: Rater Training Services, Centralized Data Services (ECG, PSG, EEG, qEEG, Actigraphy), Medical Writing Services Study Feasibility and Site Recommendation The Evolution Research Group network of Portfolio Sites and Affiliate Sites focuses on specialized populations and normal healthy volunteers.